학술논문
504P - AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v190-v190
Subject
Language
ISSN
0923-7534